3.085

0.81% -0.005

Neuronetics Inc (STIM)

Overview News Price History Option Chain Financials Discussions Forecast

Neuronetics Inc stock is traded at $3.085, with a volume of 107.45K. It is down -0.81% in the last 24 hours and up +63.03% over the past month. Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Previous Close:

$3.09

Open:

$3.11

24h Volume:

107.45K

Relative Volume:

0.05

Market Cap:

$234.31M

Revenue:

$151.64M

Net Income/Loss:

$-37.23M

P/E Ratio:

-5.646

EPS:

-0.5464

Net Cash Flow:

$-13.58M

1W Performance:

-7.12%

1M Performance:

+63.03%

6M Performance:

+137.60%

1Y Performance:

-9.32%

1-Day Range:

$3.05

$3.15

1-Week Range:

$3.025

$3.40

52-Week Range:

$0.80

$3.71

Neuronetics Inc Stock (STIM) Company Profile

Name

Neuronetics Inc

Sector

Healthcare (1084)

Industry

Medical Devices (140)

Phone

877-600-7555

Address

3222 PHOENIXVILLE PIKE, MALVERN, PA

Employee

658

Twitter

@tmstherapy

Next Earnings Date

2026-08-04

Latest SEC Filings

STIM's Discussions on Twitter

Compare STIM vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STIM Neuronetics Inc	3.075	239.26M	151.64M	-37.23M	-13.58M	-0.5464
ABT Abbott Laboratories	115.73	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.00	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	92.61	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	49.87	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.91	53.19B	6.30B	1.07B	1.09B	1.8406

Neuronetics Inc Stock (STIM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-13-24	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jul-24-18	Initiated	Canaccord Genuity	Buy

View All

Neuronetics Inc Stock (STIM) Latest News

Aug 19, 2026

Neuronetics (NASDAQ: STIM) ex-officer lines up $464K stock sale - Stock Titan

Aug 19, 2026

Aug 18, 2026

Neuronetics Expands CFO Nir Naor’s Financial Leadership Role - The Globe and Mail

Aug 18, 2026

Neuronetics (NASDAQ: STIM) holder plans $388K sale with part for taxes - Stock Titan

Aug 18, 2026

Neuronetics (STIM) Q2 2026 Earnings Call Transcript - AOL.com

Aug 18, 2026

Aug 17, 2026

Neuronetics (STIM) Edges Lower by 0.91% as Shares Navigate Key Support at $3.11Volume Weighted Price - Vinanet

Aug 17, 2026

Neuronetics (STIM) Slips to $3.25 as Shares Hover Near Key SupportPairs Trade - Vinanet

Aug 17, 2026

Neuronetics (NASDAQ:STIM) Major Shareholder Buys $44,240.00 in Stock - MarketBeat

Aug 17, 2026

Neuronetics director Jorey Chernett buys $44,240 in company stock - Investing.com

Aug 17, 2026

Neuronetics 10% owner Jorey Chernett acquires 14,000 common shares worth $44,240 - Bitget

Aug 17, 2026

Point72 discloses 5% Neuronetics (STIM) stake in new SEC ownership filing - Stock Titan

Aug 14, 2026

US$6.00That's What Analysts Think Neuronetics, Inc. (NASDAQ:STIM) Is Worth After These Results - simplywall.st

Aug 14, 2026

Aug 13, 2026

Neuronetics Q2 2026 Results: Hybrid NeuroStar Model and Greenbrook Growth Signal Strategic PivotEarnings Preview - Vinanet

Aug 13, 2026

Aug 12, 2026